应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LINE Lineage
休市中 07-11 16:00:00 EDT
42.96
-0.11
-0.26%
盘后
42.96
+0.00
0.00%
16:20 EDT
最高
43.17
最低
42.14
成交量
72.73万
今开
42.54
昨收
43.07
日振幅
2.40%
总市值
98.20亿
流通市值
30.43亿
总股本
2.29亿
成交额
3,116万
换手率
1.03%
流通股本
7,082万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅跳水5.19%报1.01美元
市场透视 · 07-10 17:18
Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅跳水5.19%报1.01美元
Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.51%报1.039美元
市场透视 · 07-09
Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.51%报1.039美元
Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.20%
市场透视 · 07-07
Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.20%
Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元
市场透视 · 07-02
Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元
Lineage Cell Therapeutics, Inc.盘中异动 早盘急速跳水5.09%报1.03美元
市场透视 · 06-25
Lineage Cell Therapeutics, Inc.盘中异动 早盘急速跳水5.09%报1.03美元
Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.22%
市场透视 · 06-24
Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.22%
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%报0.998美元
市场透视 · 06-23
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%报0.998美元
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报0.740美元
市场透视 · 06-13
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报0.740美元
花旗:维持Lineage评级,由中性调整至中性评级, 目标价由64.00美元调整至49.00美元。
金融界 · 06-12
花旗:维持Lineage评级,由中性调整至中性评级, 目标价由64.00美元调整至49.00美元。
Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.02%
市场透视 · 06-10
Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.02%
广船国际两艘双燃料汽车运输船同日出坞
国际船舶网 · 06-09
广船国际两艘双燃料汽车运输船同日出坞
招商工业威海船厂完成首个滚装船大型改装升级工程
国际船舶网 · 06-05
招商工业威海船厂完成首个滚装船大型改装升级工程
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报0.537美元
市场透视 · 05-22
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报0.537美元
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.02%
市场透视 · 05-21
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.02%
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.62%报0.489美元
市场透视 · 05-19
Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.62%报0.489美元
富国银行:维持Lineage评级,由持股观望调整至持股观望评级, 目标价由64.00美元调整至48.00美元。
金融界 · 05-19
富国银行:维持Lineage评级,由持股观望调整至持股观望评级, 目标价由64.00美元调整至48.00美元。
聚焦ArF、EUV等高阶技术布局,三星或将低阶光罩制造外包
全球半导体观察 · 05-14
聚焦ArF、EUV等高阶技术布局,三星或将低阶光罩制造外包
三星被爆:为聚焦 ArF 和 EUV 等先进技术,将外包“光掩模”生产
C114通信网 · 05-14
三星被爆:为聚焦 ArF 和 EUV 等先进技术,将外包“光掩模”生产
Lineage, Inc.盘中异动 早盘急速上涨5.00%
市场透视 · 05-12
Lineage, Inc.盘中异动 早盘急速上涨5.00%
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.68%
市场透视 · 05-12
Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.68%
加载更多
公司概况
公司名称:
Lineage
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lineage, Inc.于2017年在马里兰州成立,是世界上最大的全球温度控制仓库房地产投资信托基金,拥有现代化和战略性的房地产网络。
发行价格:
--
{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":42.96,"timestamp":1752264000000,"preClose":43.07,"halted":0,"volume":727264,"hourTrading":{"tag":"盘后","latestPrice":42.96,"preClose":42.96,"latestTime":"16:20 EDT","volume":6960,"amount":299001.6,"timestamp":1752265200502},"delay":0,"floatShares":70822263,"shares":228590171,"eps":-3.176192,"marketStatus":"休市中","change":-0.11,"latestTime":"07-11 16:00:00 EDT","open":42.54,"high":43.17,"low":42.135,"amount":31163160.58304,"amplitude":0.024031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.176192,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":43.07,"dividendRate":0.033403,"preHourTrading":{"tag":"盘前","latestPrice":43.07,"preClose":43.07,"latestTime":"04:22 EDT","volume":34,"amount":1464.38,"timestamp":1752222131203},"postHourTrading":{"tag":"盘后","latestPrice":42.96,"preClose":42.96,"latestTime":"16:20 EDT","volume":6960,"amount":299001.6,"timestamp":1752265200502},"volumeRatio":0.7798274922485284,"impliedVol":0.393,"impliedVolPercentile":0.7448},"requestUrl":"/m/hq/s/LINE","defaultTab":"news","newsList":[{"id":"2550620982","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅跳水5.19%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550620982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550620982?lang=zh_cn&edition=full","pubTime":"2025-07-11 01:18","pubTimestamp":1752167930,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日01时18分,Lineage Cell Therapeutics, Inc.股票出现异动,股价大幅下挫5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。其相关个股中,Pelthos Therapeutics Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.涨幅较大,Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为376.94%、345.08%、309.59%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 ,振幅分别为91.19%、90.07%、74.89%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4224","LINE","LENZ","LCTX","BK4539","BK4007"],"gpt_icon":0},{"id":"2550656898","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.51%报1.039美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550656898?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:12","pubTimestamp":1752070374,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分,Lineage Cell Therapeutics, Inc.股票出现波动,股价快速上涨5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。其相关个股中,Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Prokidney Corp.涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃,换手率分别为830.79%、672.72%、495.57%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Calidi Biotherapeutics, Inc.、Prokidney Corp.,振幅分别为112.02%、104.48%、48.79%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4007","LINE","LCTX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2549551344","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549551344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549551344?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:34","pubTimestamp":1751906079,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时34分,Lineage Cell Therapeutics, Inc.股票出现异动,股价大幅跳水5.20%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.61%。其相关个股中,Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为5696.87%、1202.68%、877.56%,振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.,振幅分别为298.32%、233.18%、84.08%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708003439a69b5586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708003439a69b5586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4224","BK4139","LINE","BK4539","LCTX"],"gpt_icon":0},{"id":"2548818490","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548818490?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:06","pubTimestamp":1751465187,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时06分,Lineage Cell Therapeutics, Inc.股票出现波动,股价大幅上涨5.18%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LCTX","BK4539","LENZ","LINE","BK4007","BK4139"],"gpt_icon":0},{"id":"2546245245","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘急速跳水5.09%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546245245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546245245?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:42","pubTimestamp":1750858954,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时42分,Lineage Cell Therapeutics, Inc.股票出现波动,股价急速下挫5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Plus Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大,Plus Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Portage Biotech Inc.较为活跃,换手率分别为703.36%、200.61%、144.80%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Plus Therapeutics, Inc.、内克塔治疗,振幅分别为135.80%、45.19%、26.05%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214234952b3d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214234952b3d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4007","BK4539","BK4139","BK4224","LINE","LENZ"],"gpt_icon":0},{"id":"2545123824","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545123824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545123824?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:33","pubTimestamp":1750772020,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时33分,Lineage Cell Therapeutics, Inc.股票出现异动,股价急速拉升5.22%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,内克塔治疗、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ibio, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Ibio, Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为496.10%、285.88%、217.62%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Xenetic Biosciences, Inc.、Vor Biopharma Inc.,振幅分别为33.79%、18.98%、17.52%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213340978ce948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213340978ce948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","LINE","LCTX","BK4007","BK4224","BK4139"],"gpt_icon":0},{"id":"2545417835","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417835?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:30","pubTimestamp":1750685426,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时30分,Lineage Cell Therapeutics, Inc.股票出现异动,股价急速拉升5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Impact Biomedical, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cormedix Inc.涨幅较大,Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃,换手率分别为884.34%、866.08%、192.75%,振幅较大的相关个股有Impact Biomedical, Inc.、Nucana Plc、Abpro Holdings, Inc,振幅分别为5.50%、4.10%、3.59%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213026a4b922a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213026a4b922a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4224","BK4539","LINE","BK4139","LCTX"],"gpt_icon":0},{"id":"2543361656","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543361656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543361656?lang=zh_cn&edition=full","pubTime":"2025-06-14 00:01","pubTimestamp":1749830488,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日00时01分,Lineage Cell Therapeutics, Inc.股票出现波动,股价急速上涨5.31%。截至发稿,该股报0.740美元/股,成交量40.9479万股,换手率0.18%,振幅7.15%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614000128a707dadc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614000128a707dadc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LCTX","LENZ","BK4007","LINE","BK4139","BK4224"],"gpt_icon":0},{"id":"2543254470","title":"花旗:维持Lineage评级,由中性调整至中性评级, 目标价由64.00美元调整至49.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543254470","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543254470?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:21","pubTimestamp":1749756087,"startTime":"0","endTime":"0","summary":"花旗:维持Lineage(LINE.US)评级,由中性调整至中性评级, 目标价由64.00美元调整至49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506130324179519dfc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506130324179519dfc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE"],"gpt_icon":0},{"id":"2542345800","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542345800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542345800?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:54","pubTimestamp":1749567243,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时54分,Lineage Cell Therapeutics, Inc.股票出现异动,股价快速拉升5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。其相关个股中,Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大,Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃,换手率分别为23153.03%、2542.94%、1145.52%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc,振幅分别为253.85%、191.40%、99.74%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225403a7024dc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225403a7024dc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","LINE","LCTX","BK4007","BK4224","BK4139"],"gpt_icon":0},{"id":"2542235778","title":"广船国际两艘双燃料汽车运输船同日出坞","url":"https://stock-news.laohu8.com/highlight/detail?id=2542235778","media":"国际船舶网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542235778?lang=zh_cn&edition=full","pubTime":"2025-06-09 20:37","pubTimestamp":1749472652,"startTime":"0","endTime":"0","summary":"6月8日,中国船舶集团广船国际为H-LINE航运公司建造的8600车双燃料汽车运输船2号船和为HMM航运公司建造的8600车双燃料汽车运输船1号船完成出坞。其中H-line8600车双燃料汽车运输船2号出坞前9甲以下滚装设备自动化报验完,全船区域进涂完,出坞前绝缘敷设完成82%,出坞转阶段评分97.8分,创系列船新高。在HMM公司8600车双燃料汽车运输船1号船的建造中,项目团队积极与船东船检例行沟通,对船东船检提出的重点收尾问题及时有效闭环。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100334a4a12d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100334a4a12d95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00317","BK0010","BK0279","BK0005","BK0012","LINE","BK0024","BK0183","BK0028","600685"],"gpt_icon":0},{"id":"2541885944","title":"招商工业威海船厂完成首个滚装船大型改装升级工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2541885944","media":"国际船舶网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541885944?lang=zh_cn&edition=full","pubTime":"2025-06-05 19:17","pubTimestamp":1749122226,"startTime":"0","endTime":"0","summary":"6月5日,招商工业威海船厂完成首个滚装船“Stena Foreteller”号大型改装升级工程,赢得船东高度认可。“Stena Foreteller”号改造升级工程量大,威海船厂工程管理部组织项目组成员强化安全理念,做好全面策划。“Stena Foreteller”号升级改造完工,标志招商工业威海船厂在大型船舶改装领域迈出了坚实一步,进一步了提升了公司在船舶维保市场的竞争力。Stena Line是威海船厂的长期合作伙伴,自2016年以来威海船厂已经接获了Stena RoRo总计12艘E-Flexer系列高端客滚船订单。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100547a49c36ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100547a49c36ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2537289019","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报0.537美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537289019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537289019?lang=zh_cn&edition=full","pubTime":"2025-05-22 23:26","pubTimestamp":1747927579,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日23时26分,Lineage Cell Therapeutics, Inc.股票出现异动,股价急速上涨5.01%。截至发稿,该股报0.537美元/股,成交量33.7987万股,换手率0.15%,振幅6.85%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232619aa2c972b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232619aa2c972b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4139","BK4007","BK4224","BK4539","LCTX"],"gpt_icon":0},{"id":"2537932736","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537932736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537932736?lang=zh_cn&edition=full","pubTime":"2025-05-21 23:13","pubTimestamp":1747840389,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日23时13分,Lineage Cell Therapeutics, Inc.股票出现波动,股价急速拉升5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Aptevo Therapeutics Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Polyrizon Ltd.、Nucana Plc、Aptevo Therapeutics Inc.较为活跃,换手率分别为8846.06%、862.23%、297.64%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Aptevo Therapeutics Inc.,振幅分别为659.17%、150.81%、114.10%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521231309a6e79c94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521231309a6e79c94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LINE","LCTX","BK4539","BK4224","LENZ","BK4139"],"gpt_icon":0},{"id":"2536636044","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.62%报0.489美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536636044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536636044?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:22","pubTimestamp":1747671722,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时22分,Lineage Cell Therapeutics, Inc.股票出现异动,股价快速上涨5.62%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Protagenic Therapeutics, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为12280.42%、9520.83%、2594.24%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Klotho Neurosciences, Inc.,振幅分别为862.26%、233.66%、48.80%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520002202975e821f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520002202975e821f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","LINE","LCTX","BK4224","BK4539"],"gpt_icon":0},{"id":"2536687219","title":"富国银行:维持Lineage评级,由持股观望调整至持股观望评级, 目标价由64.00美元调整至48.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687219","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687219?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:31","pubTimestamp":1747661462,"startTime":"0","endTime":"0","summary":"富国银行:维持Lineage(LINE.US)评级,由持股观望调整至持股观望评级, 目标价由64.00美元调整至48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921361194fb940a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921361194fb940a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE"],"gpt_icon":0},{"id":"2535404622","title":"聚焦ArF、EUV等高阶技术布局,三星或将低阶光罩制造外包","url":"https://stock-news.laohu8.com/highlight/detail?id=2535404622","media":"全球半导体观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535404622?lang=zh_cn&edition=full","pubTime":"2025-05-14 12:48","pubTimestamp":1747198117,"startTime":"0","endTime":"0","summary":"韩媒《The Elec》报道,三星计划将用于#存储器芯片制造的光罩生产外包。此前,为了防止技术外泄,三星一直自行生产所需的全部光罩,但该公司正评估制造低阶光罩的潜在供应商。再来,虽担心技术泄露,但三星在技术上已不再像以前一样有明显优势,因此将低阶光罩外包并不会带来太大的技术风险。由于ArF与EUV光罩将决定三星的技术竞争力,自然希望聚焦在更先进的技术领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514180523a47e00a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514180523a47e00a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2535638770","title":"三星被爆:为聚焦 ArF 和 EUV 等先进技术,将外包“光掩模”生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2535638770","media":"C114通信网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535638770?lang=zh_cn&edition=full","pubTime":"2025-05-14 09:32","pubTimestamp":1747186343,"startTime":"0","endTime":"0","summary":"韩国科技媒体 TheElec 今日报道称,三星电子正计划将内存芯片制造所需的光掩模生产业务进行外包。据报道称,三星决定将光掩模生产外包的原因有很多,主要是三星自家 i-line 和 Krf 设备已经老化,且不再生产,因此很难找到替代设备;而且低端光掩模技术外泄风险较低,三星更愿意集中力量冲击高端制程建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514093410a6de3b74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514093410a6de3b74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2534208226","title":"Lineage, Inc.盘中异动 早盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534208226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534208226?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:36","pubTimestamp":1747057007,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时36分,Lineage, Inc.股票出现波动,股价大幅上涨5.00%。Lineage, Inc.股票所在的房地产信托行业中,整体涨幅为0.52%。Lineage, Inc.公司简介:Lineage Inc是一家房地产投资信托。消息层面,截至21时36分,《麦格理:维持Norwegian Cruise Line评级,由优于大市调整至优于大市评级, 目标价由31.00美元调整至27.00美元。》资讯为影响Lineage, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213647a47b792e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213647a47b792e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2534210208","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534210208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534210208?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056749,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分,Lineage Cell Therapeutics, Inc.股票出现波动,股价急速上涨5.68%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大,Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为287.42%、60.74%、58.53%,振幅较大的相关个股有Athira Pharma, Inc.、Imunon, Inc.、Onconetix, Inc.,振幅分别为12.86%、9.99%、9.31%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221322997574448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221322997574448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4224","BK4007","LCTX","LINE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com","stockEarnings":[{"period":"1week","weight":-0.0131},{"period":"1month","weight":-0.0517},{"period":"3month","weight":-0.2},{"period":"6month","weight":-0.2255},{"period":"1year","weight":-0.4492},{"period":"ytd","weight":-0.2665}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年在马里兰州成立,是世界上最大的全球温度控制仓库房地产投资信托基金,拥有现代化和战略性的房地产网络。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}